LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Overview Fund Activity
Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

47 hedge funds and large institutions have $917K invested in LogicBio Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 6 closing their positions.

Holders
47
Holders Change
+1
Holders Change %
+2.17%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
12
Closed
6
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$6K

Top Buyers

1
Prudential Financial
1
Prudential Financial
New Jersey
$23K
2
Jane Street
2
Jane Street
New York
$18K
3
IBOK
3
Independence Bank of Kentucky
Kentucky
$15K
4
UBS Group
4
UBS Group
Switzerland
$8K
5
TRCT
5
Tower Research Capital (TRC)
New York
$8K

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$109K
2
Goldman Sachs
2
Goldman Sachs
New York
$4K
3
SCM
3
Sio Capital Management
New York
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1K
5
VF
5
Virtu Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
51
Wells Fargo
California
$0 1,226 +10 +0.8%
Simplex Trading
52
Simplex Trading
Illinois
$0 40 +40 New
GI
53
Gradient Investments
Minnesota
$0 65 +65 New
Group One Trading
54
Group One Trading
Illinois
$0 1,200 +100 +9%
HR
55
Howe & Rusling
New York
$0 150 +150 New
1 2
3